title: Low-molecular-weight heparins in patients with atrial fibrillation.
abstract: In clinical practice, low-molecular-weight heparins are used relatively frequently in patients with atrial fibrillation to prevent embolic events. In this article, it is revised the available evidence in the following clinical situations: rapid onset of anticoagulation, bridging therapy (replacing long-term oral anticoagulant therapy around an invasive procedure) and transesophageal echocardiography-guided cardioversion.
authors.affiliation: Servicio de Medicina Interna, Hospital Ciudad de Coria, Coria, Cáceres, España. Electronic address: jm.calvo@orangemail.es.
authors.forename: J M
authors.initials: JM
authors.lastname: Calvo Romero
keywords: Atrial fibrillation; Fibrilación auricular; Heparina de bajo peso molecular; Ictus; Low-molecular-weight heparin; Stroke